Bangladesh Industrial Finance Company Limited (DSE:BIFC)

G1 Therapeutics Income Statement

Financials in millions BDT. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Interest and Dividend Income	86.29	101.84	10.38	77.53	39.14	83.99
Total Interest Expense	828.58	779.96	493.62	795.47	928.89	889.34
Net Interest Income	-742.29	-678.12	-483.25	-717.94	-889.75	-805.35
Other Revenue	-0.47	-	-	-	0.04	-
Revenue Before Loan Losses	-742.76	-678.12	-483.25	-717.94	-889.71	-805.35
Provision for Loan Losses	-10.18	-18.44	31.08	-10.7	46.83	-31.72
Revenue	-732.59	-659.68	-514.32	-707.25	-936.54	-773.63
Salaries & Employee Benefits	34.54	33.47	29.28	28.76	27.57	27.7
Cost of Services Provided	19.16	19.26	24.26	24.5	21.96	19.58
Other Operating Expenses	-47.23	-47.46	1.36	-0.2	6.37	3.36
Total Operating Expenses	6.47	5.27	54.9	53.06	55.9	50.63
Operating Income	-739.06	-664.96	-569.22	-760.3	-992.45	-824.26
EBT Excluding Unusual Items	-739.06	-664.96	-569.22	-760.3	-992.45	-824.26
Gain (Loss) on Sale of Investments	-2.86	-5.56	0.03	-2.73	7.63	9.48
Pretax Income	-741.69	-670.28	-569.07	-762.93	-984.81	-814.75
Income Tax Expense	0.64	0.62	0.33	0.5	0.24	0.51
Net Income	-742.33	-670.9	-569.4	-763.42	-985.05	-815.26
Net Income to Common	-742.33	-670.9	-569.4	-763.42	-985.05	-815.26
Shares Outstanding (Basic)	101	101	101	101	101	101
Shares Outstanding (Diluted)	101	101	101	101	101	101
Shares Change (YoY)	-0.04%	-	-	-	-	-
EPS (Basic)	-7.38	-6.66	-5.66	-7.58	-9.78	-8.10
EPS (Diluted)	-7.38	-6.66	-5.66	-7.58	-9.78	-8.10
Free Cash Flow	0.65	1.18	-78.96	-213.74	-265.62	-280.1
Free Cash Flow Per Share	0.01	0.01	-0.78	-2.12	-2.64	-2.78

Updated Oct 29, 2015. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.